Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Construction in Progress (2020 - 2025)

Historic Construction in Progress for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $685000.0.

  • Insight Molecular Diagnostics' Construction in Progress rose 12682.12% to $685000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $685000.0, marking a year-over-year increase of 12682.12%. This contributed to the annual value of $340000.0 for FY2024, which is 5316.8% down from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Construction in Progress is $685000.0, which was up 12682.12% from $263000.0 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Construction in Progress ranged from a high of $3.1 million in Q1 2022 and a low of $263000.0 during Q2 2025
  • For the 5-year period, Insight Molecular Diagnostics' Construction in Progress averaged around $1.1 million, with its median value being $685000.0 (2025).
  • Its Construction in Progress has fluctuated over the past 5 years, first tumbled by 8582.79% in 2021, then surged by 73052.33% in 2022.
  • Quarter analysis of 5 years shows Insight Molecular Diagnostics' Construction in Progress stood at $1.2 million in 2021, then surged by 72.3% to $2.1 million in 2022, then tumbled by 66.07% to $726000.0 in 2023, then plummeted by 53.17% to $340000.0 in 2024, then soared by 101.47% to $685000.0 in 2025.
  • Its last three reported values are $685000.0 in Q3 2025, $263000.0 for Q2 2025, and $360000.0 during Q1 2025.